Moderna eyes producing vaccine in Asia after Japan rejected AstraZeneca – Nikkei

Dhwani Mehta FXStreet

Amid mixed vaccine developments, Moderna is considering manufacturing its covid vaccine in Japan while the country’s said it will not approve the AstraZeneca vaccine for the time being.

The government will continue monitoring blood clot cases overseas, as a side-effect of AstraZeneca’s covid vaccine.

Meanwhile, Moderna’s Chief Executive Stephane Bancel said in an interview with the Nikkei Asian Review, "We're having discussions in several countries in Asia, including Japan."

The Japanese government has made a contract with Moderna and is set to receive 50 million doses by September.

Bancel said the company is in discussions with Japan regarding additional supplies for next year. "If the government wants 50 million doses [for 2022] we can do that," he added.

Asian Stock Market: Sluggish amid mixed clues, cautious sentiment

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

GBP/USD hovers around 1.3300 after flirting with monthly lows

GBP/USD trades mildly on the defensive on Wednesday, barely holding above a multi-week trough around 1.3280. Indeed, Cable struggles to gain traction as the Greenback remains resilient ahead of the Federal Reserve announcement. Moving forward, the British Pound should remain under the microscope in light of the BoE meeting on Thursday.

EUR/USD stays offered below 1.1400 pre-Fed

EUR/USD trades in a narrow range below 1.1400 on Wednesday. The pair’s slight decline comes as the US Dollar benefits from risk aversion amid the deepening crisis in the Middle East. In the meantime, investors remain exclusively focused on the imminent FOMC event and the press conference by Chair Warsh.

Gold: The $4,000 mark holds the downside ahead of the Fed

Gold remains on the back foot on Wednesday, navigating the area just above the psychological $4,000 mark per troy ounce amid the US Dollar’s marginal advance. In the meantime, escalating tensions in the US-Iran conflict weigh on the precious metal, while investors await the FOMC event later in the day.

Bitcoin slips below support, Ethereum and XRP flash bearish signals

Bitcoin, Ethereum and Ripple remain under pressure on Wednesday after a mild correction earlier this week. BTC slips below a key support zone, and ETH is testing a key resistance zone. Meanwhile, XRP is drifting toward the psychologically important $1.00 support level.

Bitcoin muted as markets fret over Fed, crypto bill

There are two main drivers for crypto this week, keeping Bitcoin trapped within its $58,000-$65,000 summer consolidation range. The cautious tone is being set by the Fed's policy decision scheduled later on Wednesday, a key catalyst for risk assets.

US Dollar mid-year outlook: Exceptional currency, exceptional risks?

The US Dollar enters the second half of 2026 in a markedly different position from a year ago. The King currency has recovered, reflecting persistent US inflation, changing expectations for Fed policy, geopolitical tensions and renewed demand for defensive assets.